These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9590564)

  • 61. Peptide derived from insulin with regulatory activity of dopamine transporter.
    Liu Z; Wang Y; Zhao W; Ding J; Mei Z; Guo L; Cui D; Fei J
    Neuropharmacology; 2001 Sep; 41(4):464-71. PubMed ID: 11543766
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dopamine transporter mutants selectively enhance MPP+ transport.
    Kitayama S; Wang JB; Uhl GR
    Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter.
    Ingram SL; Amara SG
    J Neurosci; 2000 Jan; 20(2):550-7. PubMed ID: 10632584
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line.
    Sugamori KS; Lee FJ; Pristupa ZB; Niznik HB
    FEBS Lett; 1999 May; 451(2):169-74. PubMed ID: 10371159
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Localization of dopamine transporter protein by microscopic histochemistry.
    Kuhar MJ; Vaughan R; Uhl G; Cerruti C; Revay R; Freed C; Nirenburg M; Pickel V
    Adv Pharmacol; 1998; 42():168-70. PubMed ID: 9327870
    [No Abstract]   [Full Text] [Related]  

  • 66. HEK-293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP+) via impairment of energy metabolism.
    Storch A; Ludolph AC; Schwarz J
    Neurochem Int; 1999 Nov; 35(5):393-403. PubMed ID: 10517700
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine.
    Chen N; Justice JB
    Brain Res Mol Brain Res; 2000 Feb; 75(2):208-15. PubMed ID: 10686341
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters.
    Scholze P; Sitte HH; Singer EA
    Neurosci Lett; 2001 Aug; 309(3):173-6. PubMed ID: 11514069
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of the functional activity of the human dopamine transporter by protein kinase C.
    Zhang L; Coffey LL; Reith ME
    Biochem Pharmacol; 1997 Mar; 53(5):677-88. PubMed ID: 9113087
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.
    Park SU; Ferrer JV; Javitch JA; Kuhn DM
    J Neurosci; 2002 Jun; 22(11):4399-405. PubMed ID: 12040046
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of a single dopamine transporter cDNA can confer two cocaine binding sites.
    Boja JW; Markham L; Patel A; Uhl G; Kuhar MJ
    Neuroreport; 1992 Mar; 3(3):247-8. PubMed ID: 1515577
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug interactions with the dopamine transporter in cryopreserved human caudate.
    Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
    J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster.
    Demchyshyn LL; Pristupa ZB; Sugamori KS; Barker EL; Blakely RD; Wolfgang WJ; Forte MA; Niznik HB
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5158-62. PubMed ID: 8197200
    [TBL] [Abstract][Full Text] [Related]  

  • 74. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter.
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment.
    Hastrup H; Karlin A; Javitch JA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10055-60. PubMed ID: 11526230
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter.
    Li LB; Reith ME
    J Neurochem; 1999 Mar; 72(3):1095-109. PubMed ID: 10037481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport.
    Syringas M; Janin F; Mezghanni S; Giros B; Costentin J; Bonnet JJ
    Mol Pharmacol; 2000 Dec; 58(6):1404-11. PubMed ID: 11093780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine.
    Mitsuhata C; Kitayama S; Morita K; Vandenbergh D; Uhl GR; Dohi T
    Brain Res Mol Brain Res; 1998 May; 56(1-2):84-8. PubMed ID: 9602072
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
    Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
    Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.